Company intelligence / Profile preview

GM Collin

Montreal, Quebec, Canada

Ownership: Private
Employees: ~150
Development stage: Other

Overview

G.M. Collin is a premium dermo-corrective skincare brand that integrates natural plant and marine extracts with advanced clinical research to develop high-performance products. Founded in Paris in 1957 and currently based in Montreal, the company focuses on professional-grade solutions for various skin concerns, including aging, acne, and dehydration. Their product line is extensively used by estheticians and dermatologists in clinical settings and luxury spas worldwide. The brand is recognized for its innovative use of ingredients like peptides and stabilized retinol to achieve visible results.

Therapeutic areas: DermatologyMetabolic Disorders
Modalities: Small moleculePeptidesTopical formulations
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on GM Collin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GM Collin.

Explore the full profile